Solutia Sells Perkalink Business and Select Primary Accelerators to Lanxess
16:03 PM | November 8, 2010 | Lindsey Bewley
Solutia says it has sold its Perkalink anti-reversion agent business to Lanxess for an undisclosed sum. The company says it has also entered into a definitive agreement to sell select primary...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.